On 18/6, the Viet-Nga International Eye Hospital system was recognized by the Carl Zeiss Group (Germany) as the "unit performing the most Zeiss Smile Pro AI 4.0 surgeries in Vietnam," having successfully completed over 75,000 Zeiss Smile and Zeiss Smile Pro procedures.
![]() |
The Viet-Nga International Eye Hospital team receives recognition from the Carl Zeiss Group. Photo: Viet-Nga International Eye Hospital
Zeiss Smile Pro AI 4.0 represents the new generation of Smile refractive surgery technology. It employs a femtosecond laser system combined with AI algorithms to plan treatments with high precision. This technology reduces lenticule creation time, optimizes the surgical process, and enhances vision stability after treatment.
Compared to traditional refractive methods, Smile Pro is considered less invasive, requiring only a small incision on the cornea. This approach helps preserve corneal structure and reduces the risk of dry eyes post-surgery for suitable patient groups.
![]() |
Ms. Vu Thi Thu Hien, Chief Executive Officer of Carl Zeiss Vietnam (right), and Doctor Vitalii Bazhanov, Deputy Medical Director of the Viet-Nga International Eye Hospital system. Photo: Viet-Nga International Eye Hospital
Ms. Vu Thi Thu Hien, Chief Executive Officer of Carl Zeiss Vietnam, stated that the Viet-Nga International Eye Hospital is a strategic partner of Zeiss. The hospital has simultaneously achieved two significant milestones in refractive surgery: over 75,000 successful Zeiss Smile/Zeiss Smile Pro cases and the highest number of Zeiss Smile Pro AI 4.0 cases nationwide.
According to Ms. Hien, these results demonstrate the hospital's continuous investment in technology, its specialized team, and treatment procedures. This commitment helps bring international standard refractive surgery solutions closer to Vietnamese patients.
Doctor Vitalii Bazhanov, Deputy Medical Director of the Viet-Nga International Eye Hospital system, affirmed that this recognition from Zeiss not only reflects the volume of surgeries but also highlights years of accumulated clinical experience and standardized treatment procedures.
"This is a testament to the hospital's sustainable development in refractive surgery," Doctor Bazhanov shared, "and it motivates us to continue updating modern, safe, and more effective treatment solutions for patients."
According to ophthalmology experts, the myopia rate in Vietnam continues to increase, especially among adolescents and young working adults. This trend drives a growing demand for refractive treatment solutions that offer stable visual quality, rapid recovery times, and meet the demands of modern life.
A hospital representative indicated that, in addition to expanding the application of new technological platforms, the unit continues to invest in professional training, standardize surgical procedures, and develop a comprehensive eye care ecosystem. The unit's goal is to improve treatment quality and bring global ophthalmology advancements closer to Vietnamese patients.
Currently, the Viet-Nga International Eye Hospital system operates facilities in TP HCM, Ha Noi, Hai Phong, and Quang Ninh, implementing various ophthalmology treatment solutions with the participation of experts from Vietnam and the Russian Federation.
Yen Chi

